Respiratory Health of Elite Athletes

NCT00686491 | Completed

• 1 other identifier: CER 20141
• Study Type: observational
• Target: 133
• Locations: 1 country
• Sites: 1

Brief Summary

Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area. Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be

1. 1.to establish a long-term program of systematic evaluation and follow-up of cardiorespiratory health and performance of high elite athletes.
2. 2.to evaluate the prevalence of respiratory, circulatory and metabolic problems among high-level athletes
3. 3.to evaluate the effects of treatments on cardiorespiratory conditions and exercise performance in athletes who need asthma medication.

Conditions

Asthma; Cardiovascular Diseases; Metabolic Diseases

Keywords

Asthma; Environment; Type of sport; Cardiovascular disease; Athletes

Study Arms (5)

1

Triathletes

2

Cold air athletes

3

Swimmers

4

Other sports elite athletes

5

Control subjects

Eligibility Criteria

• Age: 14 Years - 45 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Athletes training in the province of Quebec. Controls from Quebec schools and universities.

You may qualify if:

• Athletes training more than 10 hours per week-

You may not qualify if:

• asthma or other pathologies that may interfere with the study
• Smokers
• Obese of with a BMI more than 29

Sponsors & Collaborators

• Laval University: lead

Study Sites (1)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec

Québec, Quebec, G1V4G5, Canada

Location

Related Publications (3)

• Bougault V, Blouin E, Turmel J, Boulet LP. Airway response to methacholine following eucapnic voluntary hyperpnea in athletes. PLoS One. 2015 Mar 19;10(3):e0121781. doi: 10.1371/journal.pone.0121781. eCollection 2015.

  PMID: 25789614 DERIVED

• Turmel J, Bougault V, Boulet LP, Poirier P. Exaggerated blood pressure response to exercise in athletes: dysmetabolism or altered autonomic nervous system modulation? Blood Press Monit. 2012 Oct;17(5):184-92. doi: 10.1097/MBP.0b013e3283573509.

  PMID: 22828668 DERIVED

• Bougault V, Turmel J, Boulet LP. Bronchial challenges and respiratory symptoms in elite swimmers and winter sport athletes: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010 Aug;138(2 Suppl):31S-37S. doi: 10.1378/chest.09-1689. Epub 2010 Apr 2.

  PMID: 20363843 DERIVED

Biospecimen

Retention: SAMPLES WITH DNA

Serum - plasma - sputum

MeSH Terms

Conditions

Asthma; Cardiovascular Diseases; Metabolic Diseases

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Nutritional and Metabolic Diseases

Study Officials

• Paul POIRIER, MD

  Hôpital LAval

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: May 26, 2008
• First Posted: May 29, 2008
• Study Start: June 1, 2007
• Primary Completion: December 1, 2010
• Study Completion: December 1, 2010
• Last Updated: February 23, 2011

Record last verified: 2011-02

Locations

CA (1)